scholarly journals Phase II Trial: The Combination of Tacrolimus, Sirolimus, and Rabbit Anti-Thymocyte Globulin (Thymoglobulin® Thymo) to Prevent Acute Graft-vs.-Host Disease (aGVHD) in Patients Receiving Unrelated Hematopoietic Stem Cell Transplantation (UHSCT)

2011 ◽  
Vol 17 (2) ◽  
pp. S291
Author(s):  
Z. Al-Kadhimi ◽  
Z. Gul ◽  
R. Rodriguez ◽  
W. Chen ◽  
A. Mitchell ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document